Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Elevance Health, Inc. Director's Dealing 2012

Mar 5, 2012

29933_dirs_2012-03-05_160085e5-c357-43f5-bdb3-165cec3ec815.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: WELLPOINT, INC (WLP)
CIK: 0001156039
Period of Report: 2012-03-01

Reporting Person: Gallina John E (SVP & Chief Accounting Officer)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2012-03-01 Common Stock A 8070 Acquired 30541.77 Direct
2012-03-01 Common Stock A 3511 Acquired 34052.77 Direct
2012-03-01 Common Stock F 2343 $66.23 Disposed 31709.77 Direct
2012-03-02 Common Stock F 1524 $65.78 Disposed 30185.77 Direct

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2012-03-01 Employee Stock Option (Right to Buy) $66.23 A 9560 Acquired 2019-03-01 Common Stock (9560) Direct

Footnotes

F1: Represents performance based restricted share units. Restrictions lapse as follows: 2,690 each on 3/1/12, 12/10/12 and 3/1/14.

F2: Represents restricted share units. Restrictions lapse as follows: 1,170 each on 12/10/12, 3/1/14; and 1,171 on 3/1/15.

F3: PAYMENT OF TAX LIABILITY BY WITHHOLDING STOCK INCIDENT TO THE VESTING OF PREVIOUSLY GRANTED RESTRICTED STOCK.

F4: Exercisable in four installments of 1,593 each on 9/1/12, 3/1/13, 9/1/13, 3/1/14, and two installments of 1,594 each on 9/1/14 and 3/1/15.